These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7595724)
1. Defining new standards for adjuvant therapy of testis cancer. Nichols CR; Gonin R; Foster R J Clin Oncol; 1995 Nov; 13(11):2681-3. PubMed ID: 7595724 [No Abstract] [Full Text] [Related]
2. Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis. Johnson E J Clin Oncol; 1991 Jun; 9(6):1092-4. PubMed ID: 1709684 [No Abstract] [Full Text] [Related]
3. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for stage I testicular cancer. Cullen M; James N Cancer Treat Rev; 1996 Jul; 22(4):253-64. PubMed ID: 9025783 [No Abstract] [Full Text] [Related]
5. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M; J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040 [TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the testis--lack of response to conventional chemotherapy. Crellin RP; Cornbleet MA; McIntyre MA Br J Urol; 1993 Jan; 71(1):98-9. PubMed ID: 7679601 [No Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy in pathologic Stage II nonseminomatous testicular cancer: are two cycles of etoposide-cisplatin a standard option? Culine S; Droz JP J Clin Oncol; 1996 Jul; 14(7):2187-8. PubMed ID: 8683254 [No Abstract] [Full Text] [Related]
16. Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer. Shoji S; Miyakita H; Shima M; Usui Y; Nagata Y; Uchida T; Terachi T Hinyokika Kiyo; 2006 Sep; 52(9):723-6. PubMed ID: 17040060 [TBL] [Abstract][Full Text] [Related]
17. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors. Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937 [TBL] [Abstract][Full Text] [Related]
18. Bleomycin in germ cell tumor therapy: not all regimens are created equal. Bajorin DF; Bosl GJ J Clin Oncol; 1997 May; 15(5):1717-9. PubMed ID: 9164177 [No Abstract] [Full Text] [Related]
19. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma. Peckham MJ; Horwich A; Blackmore C; Hendry WF Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750 [TBL] [Abstract][Full Text] [Related]